MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
37.59
+1.97
+5.53%
Pre Market: 37.80 +0.21 +0.56% 07:46 05/13 EDT
OPEN
36.54
PREV CLOSE
35.62
HIGH
38.02
LOW
36.26
VOLUME
1.39K
TURNOVER
271.37M
52 WEEK HIGH
67.88
52 WEEK LOW
30.04
MARKET CAP
3.25B
P/E (TTM)
-8.3241
1D
5D
1M
3M
1Y
5Y
1D
Intellia Therapeutics Shares Have Struggled, But It's Now Go-Time (Rating Upgrade)
Seeking Alpha · 22h ago
Weekly Report: what happened at CRSP last week (0505-0509)?
Weekly Report · 1d ago
Illinois Tool Works, Wynn Resorts, Agree Realty, Crispr Therapeutics, Super Micro Computer: Trending by Analysts
TipRanks · 3d ago
SA analyst downgrades: VTRS, MRVL, MAR, NTR, CRSP, DB, VRSK, OCSL
Seeking Alpha · 3d ago
Crispr Therapeutics Is Maintained at Equal-Weight by Barclays
Dow Jones · 3d ago
Crispr Therapeutics Price Target Cut to $42.00/Share From $56.00 by Barclays
Dow Jones · 3d ago
Barclays Maintains Equal-Weight on CRISPR Therapeutics, Lowers Price Target to $42
Benzinga · 3d ago
Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines
Seeking Alpha · 4d ago
More
About CRSP
More
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.
Recently
Symbol
Price
%Change

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.